Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
ICON PUBLIC LIMITED COMPANY |
Real-time Estimate
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 244.80 USD | -0.59% | -2.12% | +26.18% | |
| Sep. 20 | ICON plc Releases Expanded End-To-End Clinical Trial Tokenisation Solution | CI |
| Sep. 13 | ICON Partners With US Government for Clinical Trial of Next-Generation COVID-19 Vaccine Candidates | MT |
Financials (USD)
| Sales 2023 * | 8,147 M | Sales 2024 * | 8,674 M | Capitalization | 20 230 M |
|---|---|---|---|---|---|
| Net income 2023 * | 561 M | Net income 2024 * | 801 M | EV / Sales 2023 * | 2,90x |
| Net Debt 2023 * | 3,392 M | Net Debt 2024 * | 2,456 M | EV / Sales 2024 * | 2,62x |
| P/E ratio 2023 * | 36,2x | P/E ratio 2024 * | 25,6x | Employees | - |
| Yield 2023 * | - | Yield 2024 * | - | Free-Float | 99.28% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.34% | ||
| 1 week | -1.66% | ||
| 1 month | -6.26% | ||
| 3 months | -1.58% | ||
| 6 months | +15.29% | ||
| Current year | +26.77% |
1 week
243.85
251.48
1 month
243.85268.00
Current year
181.92268.07
1 year
171.43268.07
3 years
168.76313.00
5 years
104.28313.00
10 years
35.33313.00
| Managers | Title | Age | Since |
|---|---|---|---|
Ciaran Murray
CHM | Chairman | 60 | 2017 |
Stephen Cutler
CEO | Chief Executive Officer | 62 | 2017 |
Brendan Brennan
DFI | Director of Finance/CFO | 44 | 2012 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Linda Grais
BRD | Director/Board Member | 66 | 2017 |
Julie O'Neill
BRD | Director/Board Member | 57 | 2019 |
Stephen Cutler
BRD | Director/Board Member | 62 | 2015 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.12% | 7 M$ | +3.20% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-10-02 | 245.11 | -0.46% | 3 053 |
| 23-09-29 | 246.25 | -0.34% | 535,805 |
| 23-09-28 | 247.08 | -0.40% | 437,748 |
| 23-09-27 | 248.07 | +0.56% | 432,007 |
| 23-09-26 | 246.70 | -1.48% | 425,220 |
Delayed Quote Nasdaq, September 29, 2023 at 04:00 pm EDT
More quotes
ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors. Its sectors include Biosimilars, Biotech, Government and public health solutions, medical devices, pharmaceuticals and the IVDR journey.
Calendar
2023-10-05
- Global Site Solutions Summit
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
246.25USD
Average target price
280.50USD
Spread / Average Target
+13.91%
EPS Revisions
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| +26.77% | 20 230 M $ | |
| +0.99% | 50 M $ | |
| +36.03% | 247 M $ | |
| -.--% | 1 789 M $ | |
| -54.24% | 60 M $ | |
| -12.06% | 620 M $ | |
| -39.18% | 796 M $ | |
| -59.44% | 132 M $ | |
| +22.70% | 897 M $ | |
| +87.39% | 1 777 M $ |
